603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study

Bibliographic Details
Title: 603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study
Authors: Jyoti Malhotra, Alberto Chiappori, Salma K Jabbour, Chunxia Chen, Naomi Fujioka, Nasser H Hanna, Lawrence E Feldman, Malini Patel, Dirk Moore
Source: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Publisher Information: BMJ Publishing Group, 2023.
Publication Year: 2023
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2051-1426
Relation: https://doaj.org/toc/2051-1426
DOI: 10.1136/jitc-2023-SITC2023.0603
Access URL: https://doaj.org/article/edb5bb1d7a984bf9ac497fa785f2f4b7
Accession Number: edsdoj.b5bb1d7a984bf9ac497fa785f2f4b7
Database: Directory of Open Access Journals
More Details
ISSN:20511426
DOI:10.1136/jitc-2023-SITC2023.0603
Published in:Journal for ImmunoTherapy of Cancer
Language:English